A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 228 participants.
Also called NCT07021976
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 228 participants
- Registry
-
NCT07021976
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07021976. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-11 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
- Condition
- Obstructive Hypertrophic Cardiomyopathy
- Intervention (Drug)
- HRS-1893 Tablets
- Intervention (Drug)
- HRS-1893 Placebo Tablets
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct07021976- Content hash
432416e0e32ee1e2ab90dfc04e09de0c3e28024f31fa8de10dba609108b6c7c2